| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1Institute of Anatomy and Cell Biology, University of Würzburg, D-97070 Würzburg; and 3Department of Pharmacology and Toxicology, Albert-Ludwig University, D-79104 Freiburg, Germany; and 2Department of Physiology and Membrane Biology, University of California, Davis, California 95616
Submitted 10 June 2004 ; accepted in final form 21 July 2004
cAMP enhances endothelial barrier properties and is protective against various inflammatory mediators both in vivo and in vitro. However, the mechanisms whereby cAMP stabilizes the endothelial barrier are largely unknown. Recently we demonstrated that the Rho family GTPase Rac-1 is required for maintenance of endothelial barrier functions in vivo and in vitro. Therefore, in the present study we investigated the effect of forskolin (5 µM)- and rolipram (10 µM)-induced cAMP increase on reduction of barrier functions in response to Rac-1 inhibition by Clostridium sordellii lethal toxin (LT). Forskolin and rolipram treatment blocked LT (200 ng/ml)-induced hydraulic conductivity (Lp) increase in mesenteric microvessels in vivo. Likewise, LT-induced intercellular gap formation in monolayers of cultured microvascular myocardial endothelial (MyEnd) cells and LT-induced loss of adhesion of vascular endothelial cadherin-coated microbeads were abolished. Inhibition of PKA by myristoylated inhibitor peptide (14–22) of PKA (100 µM) reduced the protective effect of cAMP on LT-induced Lp increase in vivo and gap formation in vitro, indicating that the effect of cAMP on Rac-1 inhibition was PKA dependent. Glucosylation assays demonstrated that cAMP prevents inhibitory Rac-1 glucosylation by LT, indicating that one way that cAMP enhances endothelial barrier functions may be by regulating Rac-1 signaling. Our study suggests that cAMP may provide its well-established protective effects at least in part by regulation of Rho proteins.
permeability; Rho proteins; cAMP-dependent protein kinase; vascular endothelial cadherin
This article has been cited by other articles:
|
|
 |
|
  J. Qiao, O. Holian, B.-S. Lee, F. Huang, J. Zhang, and H. Lum Phosphorylation of GTP dissociation inhibitor by PKA negatively regulates RhoA Am J Physiol Cell Physiol, November 1, 2008; 295(5): C1161 - C1168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Dejana, F. Orsenigo, and M. G. Lampugnani The role of adherens junctions and VE-cadherin in the control of vascular permeability J. Cell Sci., July 1, 2008; 121(13): 2115 - 2122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Adamson, J. C. Ly, R. K. Sarai, J. F. Lenz, A. Altangerel, D. Drenckhahn, and F. E. Curry Epac/Rap1 pathway regulates microvascular hyperpermeability induced by PAF in rat mesentery Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1188 - H1196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Schlegel, S. Burger, N. Golenhofen, U. Walter, D. Drenckhahn, and J. Waschke The role of VASP in regulation of cAMP- and Rac 1-mediated endothelial barrier stabilization Am J Physiol Cell Physiol, January 1, 2008; 294(1): C178 - C188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.V. Hartel, C.W. Rodewald, M. Aslam, D. Gunduz, L. Hafer, J. Neumann, H.M. Piper, and T. Noll Extracellular ATP induces assembly and activation of the myosin light chain phosphatase complex in endothelial cells Cardiovasc Res, June 1, 2007; 74(3): 487 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Lorenowicz, M. Fernandez-Borja, and P. L. Hordijk cAMP Signaling in Leukocyte Transendothelial Migration Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1014 - 1022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Mehta and A. B. Malik Signaling Mechanisms Regulating Endothelial Permeability Physiol Rev, January 1, 2006; 86(1): 279 - 367. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
